DayTrading After-Market lounge 21stMay, page-52

  1. 143 Posts.
    PRR phenomenal run from 2c to a high of 19c today on the back of positive results for their covarian cancer drug.

    PAA will run off the back of this. capped at $12mill with an equally promising cancer drug which has shown massive upside with trials ongoing.

    Should move to 2c and then push to 5c and beyond. Their aim is to replace a $6.4billion per annum cancer drug and although its early stages... its looking good.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.